Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Express Scripts
Harvard Business School
McKinsey
Johnson and Johnson

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Methscopolamine bromide - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for methscopolamine bromide
Pharmacology for methscopolamine bromide
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Synonyms for methscopolamine bromide
(-)-(1S,3s,5R,6R,7S)-6,7-epoxy-8-methyl-3-[(S)-tropoyloxy]tropanium bromide
(-)-scopolamine methobromide
(-)-Scopolamine methyl bromide
(-)-Scopolamine methyl bromide, >=98% (HPLC), powder
(1R,2R,4S,5S,7s)-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide
(1R,2R,4S,5S,7s)-7-[[(2S)-3-Hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide (Methylhyoscine Bromide)
(1R,2R,4S,5S,7s)-7-[[(2S)-3-Hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide
(1R,2R,4S,5S,7S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide
(1R,2R,4S,5S,7s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane
(1R,2R,4S,5S,7S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromidebromide
(1S,2R,4S,5S)-7-((3-hydroxy-2-phenylpropanoyl)oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide
(1s,2r,4s,5s)-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide
(1S,5S,7R)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide
(1S,5S,7R)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0;{2,4}]nonan-9-ium bromide
(S)-6beta,7beta-Epoxy-8-methyl-3alpha-(-)-tropoyloxy-1alphaH,5alphaH-tromanium bromide
1-alpha-H,5-alpha-H-Tropanium, 6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide, (-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropanium, 6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide,(-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropanium,6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide, (-)-tropate (ester)
13265-10-6 (Parent)
1420-31-1
155-41-9
1alphaH,5alphaH-Tropanium, 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-, bromide, (-)-tropate
1alphaH,5alphaH-Tropanium, 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-, bromide, (-)-tropate (8CI)
2660-04-0
3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-
3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((2S)-3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide (1:1), (1alpha,2beta,4beta,5alpha,7beta)-
3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((2S)-3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide, (1alpha,2beta,4beta,5alpha,7beta)-
6beta,7beta-Epoxy-3alpha-hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide (-)-tropate
7-(3-Hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-3-oxo-9-azoniatricyclo-(3.3.1.0(2,4))nonane bromide
9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0<2,4>]non-7-yl 3-hydroxy-2-phenylpropa noate, bromide
AB2000400
AC1L1S97
AC1Q1R9E
AC1Q1RGR
AKOS024287992
AKOS026749843
AKOS030524090
Ampyrox
API0004143
Blocan
C18H24NO4.HBr
CAS-155-41-9
CCG-39279
CHEBI:61276
CHEBI:6845
CHEMBL1201024
CHEMBL1354199
CHEMBL293927
CHEMBL3091667
CS-2386
CTK4F8213
D00715
Daipin
DB00462
Diopal
DS-3286
DSSTox_CID_20608
DSSTox_GSID_40608
DSSTox_RID_79509
DTXSID2040608
EC 205-844-5
EINECS 205-844-5
Epoxymethamine bromide
Epoxytropine tropate methylbromide
HMS1920N07
HMS2091D22
HMS2231A18
HMS2235K24
HMS3373D05
HMS3373M11
HMS501C19
Holopon
HSDB 5420
HY-B0344
Hyoscin methobromide
Hyoscin-N-methylbromid
Hyoscine Butylbromide Impurity C
Hyoscine Methobromide
Hyoscine methobromide (INN)
Hyoscine methyl bromide
Hyoscine methylbromide
KS-00000GJL
Lescopine bromide
LS-157838
MCULE-4003028645
Mescopil
Methoscopylamine bromide
methscopolamine
Methscopolamine (bromide)
Methscopolamine (Pamine)
Methscopolamine bromide (USP)
Methscopolamine bromide [USP]
Methscopolamine bromide, United States Pharmacopeia (USP) Reference Standard
Methscopolamine methylbromide
Methylhyoscine Bromide (Methscopolamine Bromide)
Methylscopolamine bromide
Methylscopolamine hydrobromide
MFCD00078560
MLS000069754
MLS001076542
MolPort-016-633-266
N-Methylhyoscine bromide
N-Methylhyoscinium bromide
N-Methylscopolamine Bromide
n-methylscopolamine methylsulfate
N-Methylscopolammonium bromide
NCGC00013724-01
NCGC00022697-03
NCGC00094389-01
NCGC00094723-01
NCGC00094723-02
Neo-Avagal
NSC 120606
NSC-757103
NSC757103
Nutrop
Opera_ID_514
Oxitropium bromide impurity B, European Pharmacopoeia (EP) Reference Standard
Pamine
Pamine (TN)
Pamine Forte
Paraspan
Pharmakon1600-01500401
Proscomide
Restropin
RTN51LK7WL
S0231
s1978
SCHEMBL152483
SCHEMBL1652312
SCHEMBL265648
Scopolamin methylbromide
Scopolamin-N-methylbromid
Scopolamine methobromide
scopolamine methyl bromide
Scopolamine methyl bromide;Pamine
Scopolamine methylbromide
Scopolammonium, N-methyl-, bromide
SCOPOLAMMONIUM, N-METHYLBROMIDE
Scordin
SMR000058794
SMR000653474
SPECTRUM1500401
SR-01000076123
SR-01000076123-4
SR-01000076123-5
ST51037430
SW219038-1
Tox21_110037
Tox21_110037_1
U 0382
UNII-RTN51LK7WL

US Patents and Regulatory Information for methscopolamine bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 040624-002 Dec 28, 2006 AA RX No Yes   Start Trial   Start Trial   Start Trial
Pvt Form METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 080970-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Vintage Pharms METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 040624-001 Dec 28, 2006 AA RX No Yes   Start Trial   Start Trial   Start Trial
Bayshore Pharms Llc METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 200602-002 Sep 24, 2012 AA RX No No   Start Trial   Start Trial   Start Trial
Fougera Pharms PAMINE FORTE methscopolamine bromide TABLET;ORAL 008848-002 Mar 25, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Breckenridge Pharm METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 040642-002 Dec 6, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Dow
Merck
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.